Occuity wins £2.85m to develop optical glucose meter

News

Medical tech start-up Occuity has secured £2.85m to develop a non-contact glucose meter, allowing people with diabetes to monitor their blood sugar levels through an eye scan.

The Berkshire-based company has raised the largest MedTech financing deal on crowdfunding platform Seedrs, having reached its original £1.8m target within 24 hours of launch to develop the ‘Occuity Indigo’ meter.

Comprising experts in optics, mechanical engineering and industrial design, the team is collaborating with industry and academic institutions including the Royal Berkshire Hospital and Bristol University.

While described as ‘ground-breaking’ in the context of diabetes management, investors were reportedly attracted by the potential usage of the company’s patented optical technology for a range of conditions including glaucoma, myopia and eventually, it is hoped, early detection of Alzheimer’s disease.

Occuity design director Daniele De Iuliis said that the way we monitor chronic diseases like diabetes has been routed in inconvenient, uncomfortable or painful and repetitive finger stick blood testing – whereas, in comparison, Occuity Indigo will be a discrete handheld product offering a ‘long overdue’ pain-free 21st century solution.

MORE MEDICAL AND HEALTHCARE

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox

Register
Or continue by

Signing in with your registered email address